Document is current

Any future updates will be listed below

Correction to: Eltrombopag is effective in patients with relapse/refractory aplastic anemia—report from a single center in China

Crossref DOI link: https://doi.org/10.1007/s00277-020-04301-1

Published Online: 2020-11-02

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark